Shuttle Pharmaceuticals Holdings, Inc. — Form D

Shuttle Pharmaceuticals Holdings, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-04. The offering totals $500K, of which $500K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Peter DritschiloDirectorGaithersburg, MD
Josh SchaferDirectorRockville, MD
Yuying LiangRelated PersonGAITHERSBURG, MD
Christopher CooperDirectorGAITHERSBURG, MD
Christopher CooperExecutive OfficerGAITHERSBURG, MD
Christopher CooperRelated PersonGAITHERSBURG, MD
Tyvin RichExecutive OfficerGaithersburg, MD
Adam ChambersDirectorGAITHERSBURG, MD
Adam ChambersRelated PersonGAITHERSBURG, MD
Mira JungExecutive OfficerGaithersburg, MD
Angel LirianoDirectorGAITHERSBURG, MD
Angel LirianoRelated PersonGAITHERSBURG, MD
Sachin PathigodaDirectorGaithersburg, MD
George ScorsisDirectorGAITHERSBURG, MD
George ScorsisRelated PersonGAITHERSBURG, MD
Timothy LorberExecutive OfficerGaithersburg, MD
Oleh NabytDirectorGaithersburg, MD
George ScorcisDirectorGaithersburg, MD
Steven RichardsDirectorGaithersburg, MD
Joseph TungDirectorGaithersburg, MD
Peter DritschiloExecutive OfficerGaithersburg, MD
Joshua SchaferDirectorGaithersburg, MD
Chris SenanayakeDirectorGaithersburg, MD
Michael Vander HoekExecutive OfficerGaithersburg, MD
Bette JacobsDirectorGaithersburg, MD

Other filings by this issuer (8)

FiledFormOfferingSold
2026-05-15D$10.0M$10.0M
2025-11-07D$2.5M$2.5M
2025-06-26D$4.3M$4.3M
2024-10-25D$1.3M$790K
2023-01-20D$4.0M$4.0M
2022-08-15D$500K$125K
2022-02-22D$2.0M$365K
2019-01-31D—$913K

More